Andrew Seth Sandler - 06 Oct 2022 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Director
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Issuer symbol
DRMA
Transactions as of
06 Oct 2022
Net transactions value
$0
Form type
4
Filing time
07 Oct 2022, 17:06:16 UTC
Previous filing
18 Aug 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Award $0 +10,120 +72% $0.000000 24,184 06 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 6, 2022, the Reporting Person was granted 10,120 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.